GleamWall
中文EN

BDMD Baird Medical Investment Holdings Ltd Annual reports only

Surgical & Medical Instruments & Apparatus · Nasdaq · SEC CIK 1982444 · Fiscal year ends 12/31

Financial factors as of 2025-12-31 (FY2025), by fiscal year; growth vs the previous fiscal year

Growth

TTM revenue YoY-39.2%
TTM net income YoY-319.0%
TTM EPS YoY-271.9%
Revenue 3-yr CAGR-13.7%
Net income 3-yr CAGR—

Margins

Gross margin83.8%
Operating margin-113.7%
Net margin-121.0%
FCF margin-6.2%
EBITDA margin-108.8%

Returns

ROE-76.8%
ROA-36.9%
ROIC (approx.)-50.1%
Asset turnover0.31x

Leverage & solvency

Liabilities / assets55.2%
Debt / equity0.28x
Current ratio1.70x
Interest coverage-72.33x

Cash quality & payout

Operating cash flow / net income0.05x
Accruals ratio-35.1%
Payout ratio—
Capex / revenue0.2%

Factor history charts and full statement history on Pro 🔒

Financial statements

Annual Quarterly (none) Export CSV 🔒
Line item FY20252025-12-31FY20242024-12-31
Income statement
Revenue$22.54M$37.04M
Cost of revenue$3.65M$4.38M
Gross profit$18.88M$32.65M
R&D expense$20.13M$6.17M
SG&A expense$14.12M$7.10M
Operating income-$25.63M$15.32M
Interest expense$354,341$388,613
Pretax income-$26.37M$14.09M
Income tax$1.17M$1.49M
Net income-$27.28M$12.45M
EBITDA-$24.53M$16.45M
EPS (basic)-0.980.57
EPS (diluted)-0.980.57
Weighted avg. shares (diluted)27.79M21.83M
Balance sheet
Cash & equivalents$178,321$2.97M
Receivables$42.53M$46.58M
Inventory$1.09M$1.30M
Current assets$54.97M$61.42M
PP&E, net$6.37M$7.14M
Goodwill$60,303$57,772
Intangibles$8,626$16,528
Total assets$69.70M$77.96M
Current liabilities$32.36M$34.62M
Short-term debt$2.64M$867,772
Long-term debt$6.09M$3.44M
Total debt$8.72M$4.31M
Total liabilities$38.48M$38.20M
Shareholders' equity$31.37M$39.66M
Net debt$8.54M$1.34M
Shares outstanding30.75M25.56M
Cash flow statement
Operating cash flow-$1.34M-$6.31M
Capital expenditure$42,315$2.85M
Free cash flow-$1.39M-$9.17M
Investing cash flow-$42,315-$2.47M
Financing cash flow-$1.39M$10.33M
Depreciation & amortization$1.10M$1.14M
Stock-based compensation$17.47M$0

Free plan shows the latest 2 periods; Pro shows all 4 🔒

· This company files only annual reports with the SEC (20-F for foreign issuers), so there is no quarterly data; factors are by fiscal year and growth is vs the previous fiscal year.

· No price-based ratios such as P/E or P/B (the site uses no licensed market data). Blanks are shown as —.

Source: SEC EDGAR XBRL (financial statements filed with the SEC), updated 2026-11-21 06:27.